| Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) DJ Klionsky, ..., PL Lorenzi Autophagy 12 (1), 1-222, 2016 | 13470* | 2016 |
| The cancer genome atlas pan-cancer analysis project JN Weinstein, EA Collisson, GB Mills, KR Shaw, BA Ozenberger, K Ellrott, ... Nature genetics 45 (10), 1113-1120, 2013 | 6437 | 2013 |
| Comprehensive molecular characterization of urothelial bladder carcinoma Cancer Genome Atlas Research Network Nature 507 (7492), 315, 2014 | 2600 | 2014 |
| Measurement of DNA concentration as a normalization strategy for metabolomic data from adherent cell lines LP Silva, PL Lorenzi, P Purwaha, V Yong, DH Hawke, JN Weinstein Analytical chemistry 85 (20), 9536-9542, 2013 | 504 | 2013 |
| CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1/PD-L1 blockade L Chen, L Diao, Y Yang, X Yi, BL Rodriguez, Y Li, PA Villalobos, ... Cancer discovery 8 (9), 1156-1175, 2018 | 369 | 2018 |
| MicroRNA expression profiles for the NCI-60 cancer cell panel PE Blower, JS Verducci, S Lin, J Zhou, JH Chung, Z Dai, CG Liu, ... Molecular cancer therapeutics 6 (5), 1483-1491, 2007 | 309 | 2007 |
| Molecular characterization and clinical relevance of metabolic expression subtypes in human cancers X Peng, Z Chen, F Farshidfar, X Xu, PL Lorenzi, Y Wang, F Cheng, L Tan, ... Cell reports 23 (1), 255-269. e4, 2018 | 228 | 2018 |
| Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma L Zhang, Y Yao, S Zhang, Y Liu, H Guo, M Ahmed, T Bell, H Zhang, G Han, ... Science translational medicine 11 (491), eaau1167, 2019 | 202 | 2019 |
| The glutaminase activity of l-asparaginase is not required for anticancer activity against ASNS-negative cells WK Chan, PL Lorenzi, A Anishkin, P Purwaha, DM Rogers, S Sukharev, ... Blood, The Journal of the American Society of Hematology 123 (23), 3596-3606, 2014 | 182 | 2014 |
| DNA fingerprinting of the NCI-60 cell line panel PL Lorenzi, WC Reinhold, S Varma, AA Hutchinson, Y Pommier, ... Molecular cancer therapeutics 8 (4), 713-724, 2009 | 175 | 2009 |
| Epigenetic reprogramming of cancer-associated fibroblasts deregulates glucose metabolism and facilitates progression of breast cancer LM Becker, JT O’Connell, AP Vo, MP Cain, D Tampe, L Bizarro, ... Cell reports 31 (9), 2020 | 172 | 2020 |
| ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies JO Ishizawa, K Kojima, D Chachad, P Ruvolo, V Ruvolo, RO Jacamo, ... Science signaling 9 (415), ra17-ra17, 2016 | 170 | 2016 |
| mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities H Liu, P D'Andrade, S Fulmer-Smentek, P Lorenzi, KW Kohn, ... Molecular cancer therapeutics 9 (5), 1080-1091, 2010 | 160 | 2010 |
| Amino acid metabolism in hematologic malignancies and the era of targeted therapy Y Tabe, PL Lorenzi, M Konopleva Blood, The Journal of the American Society of Hematology 134 (13), 1014-1023, 2019 | 159 | 2019 |
| A pan-cancer analysis reveals high-frequency genetic alterations in mediators of signaling by the TGF-β superfamily A Korkut, S Zaidi, RS Kanchi, S Rao, NR Gough, A Schultz, X Li, ... Cell systems 7 (4), 422-437. e7, 2018 | 143 | 2018 |
| Amino acid ester prodrugs of the anticancer agent gemcitabine: synthesis, bioconversion, metabolic bioevasion, and hPEPT1-mediated transport X Song, PL Lorenzi, CP Landowski, BS Vig, JM Hilfinger, GL Amidon Molecular pharmaceutics 2 (2), 157-167, 2005 | 139 | 2005 |
| PTEN suppresses glycolysis by dephosphorylating and inhibiting autophosphorylated PGK1 X Qian, X Li, Z Shi, Y Xia, Q Cai, D Xu, L Tan, L Du, Y Zheng, D Zhao, ... Molecular Cell 76 (3), 516-527. e7, 2019 | 138 | 2019 |
| Asparagine synthetase as a causal, predictive biomarker for l-asparaginase activity in ovarian cancer cells PL Lorenzi, WC Reinhold, M Rudelius, M Gunsior, U Shankavaram, ... Molecular cancer therapeutics 5 (11), 2613-2623, 2006 | 138 | 2006 |
| Amino acid ester prodrugs of the antiviral agent 2-bromo-5, 6-dichloro-1-(β-D-ribofuranosyl) benzimidazole as potential substrates of hPEPT1 transporter X Song, BS Vig, PL Lorenzi, JC Drach, LB Townsend, GL Amidon Journal of medicinal chemistry 48 (4), 1274-1277, 2005 | 133 | 2005 |
| EGFR-phosphorylated platelet isoform of phosphofructokinase 1 promotes PI3K activation JH Lee, R Liu, J Li, Y Wang, L Tan, XJ Li, X Qian, C Zhang, Y Xia, D Xu, ... Molecular cell 70 (2), 197-210. e7, 2018 | 132 | 2018 |
John N WeinsteinMD Anderson Cancer CenterVerified email at mdanderson.org
